Skip to content

Mave Health Raises $3.5M to Scale Brain-Stimulating Wearables for Focus and Mood

A sleek, 100-gram headset could redefine mental wellness. Backed by top investors, Mave Health's brain-stimulating tech is now open for pre-order—with a 2026 launch.

The image shows a group of people wearing headsets and working on computers in a control room....
The image shows a group of people wearing headsets and working on computers in a control room. There are monitors, keyboards, and other objects on the table, and lights on the ceiling. The background is slightly blurred, giving the image a sense of focus on the people and their work.

Mave Health Raises $3.5M to Scale Brain-Stimulating Wearables for Focus and Mood

Mave Health, a startup specialising in brain-stimulating wearables, has secured $3.5 million in seed funding. The company, founded in 2023, develops lightweight headsets designed to enhance focus, mood, and stress management. This latest investment follows an earlier $750,000 pre-seed round in late 2023.

The funding round was led by Lachy Groom, with contributions from Inuka Capital, Stanford Angels, Aureolis Ventures, and All In Capital. Angel investors, including Dhaval Shroff and Raymond Russell, also participated. The new capital will primarily support scaling up manufacturing for Mave Health's flagship product.

The startup's headset uses transcranial direct current stimulation (tDCS), a non-invasive method to stimulate brain activity. Weighing around 100 grams, it is intended for 20-minute daily sessions during everyday tasks. Operating at 1-2 mA intensity, the device can last up to a month on a single charge. A companion mobile app lets users log sessions, adjust settings, and monitor progress—without collecting brain data. The headset is currently available for pre-order at $495, with shipments scheduled to start in April 2026. Mave Health was established by Dhawal Jain, Jai Sharma, and Aman Kumar. The company maintains offices in both San Francisco and Bengaluru, focusing on mental wellness through accessible technology.

With the new funding, Mave Health plans to expand production of its tDCS headset. The device aims to offer a practical solution for improving cognitive and emotional well-being. Pre-orders are open, with deliveries set to begin in early 2026.

Read also:

Latest